Clark Capital Management Group »

Soleno Therapeutics shares owned by Clark Capital Management Group

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Clark Capital Management Group from 13F filings

Historical chart of Clark Capital Management Group investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Clark Capital Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Clark Capital Management Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.3M 180k 46.30

More positions owned by Clark Capital Management Group

Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr Series Trust State Street Spd (SPYM)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust State Street Spd (JNK)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Total (IXUS)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Scp Etf (IJR)
Morgan Stanley Com New (MS)
Amazon (AMZN)

View all positions for Clark Capital Management Group

Top funds holding Soleno Therapeutics

FMR
BlackRock
Wellington Management Company
Vanguard Group
venBio Select Advisor
State Street Corporation
Nantahala Capital Management
Millennium Management
Commodore Capital
Braidwell
Geode Capital Management
Polar Capital Holdings
Woodline Partners
Deep Track Capital
Goldman Sachs Group

View all funds holding Soleno Therapeutics